34 results on '"Schilling, Bastian"'
Search Results
2. Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade
3. Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial
4. Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study
5. Clinical, histopathological and molecular features of dedifferentiated melanomas: An EORTC Melanoma Group Retrospective Analysis
6. Neoadjuvant ipilimumab plus nivolumab in locally advanced melanoma: A real-world single-centre retrospective study
7. Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial
8. Model soups improve performance of dermoscopic skin cancer classifiers
9. Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts
10. A benchmark for neural network robustness in skin cancer classification
11. Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases
12. Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classification
13. Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma
14. Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition
15. Robustness of convolutional neural networks in recognition of pigmented skin lesions
16. Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group ‘Molecular Diagnostics and Therapy’
17. Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial
18. Superior skin cancer classification by the combination of human and artificial intelligence
19. Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data
20. Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks
21. Deep neural networks are superior to dermatologists in melanoma image classification
22. Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma
23. Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task
24. A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task
25. Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark
26. Community-driven development of a modified progression-free survival ratio for precision oncology
27. Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade
28. Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis
29. Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
30. Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient
31. Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
32. Oncogene status as a diagnostic tool in ocular and cutaneous melanoma
33. Surveillance of patients with conjunctival melanoma in German-speaking countries: A multinational survey of the German dermatologic cooperative oncology group
34. Corrigendum to ‘Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data’ [Eur J Cancer, 119 (September 2019) Pages 30–34]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.